-
1
-
-
0037180757
-
Inflammation and cancer
-
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860-7.
-
(2002)
Nature
, vol.420
, Issue.6917
, pp. 860-867
-
-
Coussens, L.M.1
Werb, Z.2
-
2
-
-
47949096781
-
Cancer-related inflammation
-
Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44.
-
(2008)
Nature
, vol.454
, Issue.7203
, pp. 436-444
-
-
Mantovani, A.1
Allavena, P.2
Sica, A.3
Balkwill, F.4
-
3
-
-
65549146877
-
Systemic inflammation, nutritional status and survival in patients with cancer
-
McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223-6.
-
(2009)
Curr Opin Clin Nutr Metab Care
, vol.12
, Issue.3
, pp. 223-226
-
-
McMillan, D.C.1
-
4
-
-
17644394616
-
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
-
Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7(3):211-7.
-
(2005)
Cancer Cell
, vol.7
, Issue.3
, pp. 211-217
-
-
Balkwill, F.1
Charles, K.A.2
Mantovani, A.3
-
5
-
-
77956646156
-
Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma
-
Ohno Y, Nakashima J, Ohori M, Hatano T, Tachibana M. Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. J Urol. 2010;184(3):873-8.
-
(2010)
J Urol
, vol.184
, Issue.3
, pp. 873-878
-
-
Ohno, Y.1
Nakashima, J.2
Ohori, M.3
Hatano, T.4
Tachibana, M.5
-
6
-
-
77955862760
-
Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
-
An X, Ding PR, Li YH, Wang FH, Shi YX, Wang ZQ, et al. Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers. 2010;15(6):516-22.
-
(2010)
Biomarkers
, vol.15
, Issue.6
, pp. 516-522
-
-
An, X.1
Ding, P.R.2
Li, Y.H.3
Wang, F.H.4
Shi, Y.X.5
Wang, Z.Q.6
He, Y.J.7
Xu, R.H.8
Jiang, W.Q.9
-
7
-
-
84881151227
-
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
-
Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, et al. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncolsss. 2013;114(1):149-54.
-
(2013)
J Neurooncolsss
, vol.114
, Issue.1
, pp. 149-154
-
-
Bambury, R.M.1
Teo, M.Y.2
Power, D.G.3
Yusuf, A.4
Murray, S.5
Battley, J.E.6
Drake, C.7
O'Dea, P.8
Bermingham, N.9
Keohane, C.10
-
8
-
-
54849431185
-
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment
-
Cho H, Hur HW, Kim SW, Kim SH, Kim JH, Kim YT, et al. Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother. 2009;58(1):15-23.
-
(2009)
Cancer Immunol Immunother
, vol.58
, Issue.1
, pp. 15-23
-
-
Cho, H.1
Hur, H.W.2
Kim, S.W.3
Kim, S.H.4
Kim, J.H.5
Kim, Y.T.6
Lee, K.7
-
9
-
-
48549088033
-
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma
-
Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JP, et al. Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg. 2008;32(8):1757-62.
-
(2008)
World J Surg
, vol.32
, Issue.8
, pp. 1757-1762
-
-
Gomez, D.1
Farid, S.2
Malik, H.Z.3
Young, A.L.4
Toogood, G.J.5
Lodge, J.P.6
Prasad, K.R.7
-
10
-
-
84860449392
-
Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy
-
Gondo T, Nakashima J, Ohno Y, Choichiro O, Horiguchi Y, Namiki K, et al. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy. Urology. 2012;79(5):1085-91.
-
(2012)
Urology
, vol.79
, Issue.5
, pp. 1085-1091
-
-
Gondo, T.1
Nakashima, J.2
Ohno, Y.3
Choichiro, O.4
Horiguchi, Y.5
Namiki, K.6
Yoshioka, K.7
Ohori, M.8
Hatano, T.9
Tachibana, M.10
-
11
-
-
84876986843
-
The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer
-
McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534-40.
-
(2013)
Cancer Treat Rev
, vol.39
, Issue.5
, pp. 534-540
-
-
McMillan, D.C.1
-
12
-
-
79951676213
-
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
-
Proctor MJ, Morrison DS, Talwar D, Balmer SM, O'Reilly DS, Foulis AK, et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer. 2011;104(4):726-34.
-
(2011)
Br J Cancer
, vol.104
, Issue.4
, pp. 726-734
-
-
Proctor, M.J.1
Morrison, D.S.2
Talwar, D.3
Balmer, S.M.4
O'Reilly, D.S.5
Foulis, A.K.6
Horgan, P.G.7
McMillan, D.C.8
-
13
-
-
80755128486
-
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study
-
Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, et al. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer. 2011;47(17):2633-41.
-
(2011)
Eur J Cancer
, vol.47
, Issue.17
, pp. 2633-2641
-
-
Proctor, M.J.1
Morrison, D.S.2
Talwar, D.3
Balmer, S.M.4
Fletcher, C.D.5
O'Reilly, D.S.6
Foulis, A.K.7
Horgan, P.G.8
McMillan, D.C.9
-
14
-
-
62649085200
-
Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma
-
Smith RA, Bosonnet L, Raraty M, Sutton R, Neoptolemos JP, Campbell F, et al. Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma. Am J Surg. 2009;197(4):466-72.
-
(2009)
Am J Surg
, vol.197
, Issue.4
, pp. 466-472
-
-
Smith, R.A.1
Bosonnet, L.2
Raraty, M.3
Sutton, R.4
Neoptolemos, J.P.5
Campbell, F.6
Ghaneh, P.7
-
15
-
-
48849090158
-
Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio
-
Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, Neoptolemos JP. Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg. 2008;12(8):1422-8.
-
(2008)
J Gastrointest Surg
, vol.12
, Issue.8
, pp. 1422-1428
-
-
Smith, R.A.1
Ghaneh, P.2
Sutton, R.3
Raraty, M.4
Campbell, F.5
Neoptolemos, J.P.6
-
16
-
-
78149473072
-
The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer
-
Kasymjanova G, MacDonald N, Agulnik JS, Cohen V, Pepe C, Kreisman H, et al. The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer. Curr Oncol. 2010;17(4):52-8.
-
(2010)
Curr Oncol
, vol.17
, Issue.4
, pp. 52-58
-
-
Kasymjanova, G.1
MacDonald, N.2
Agulnik, J.S.3
Cohen, V.4
Pepe, C.5
Kreisman, H.6
Sharma, R.7
Small, D.8
-
17
-
-
60449118650
-
Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy
-
Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN. Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncolss. 2009;16(3):614-22.
-
(2009)
Ann Surg Oncolss
, vol.16
, Issue.3
, pp. 614-622
-
-
Kishi, Y.1
Kopetz, S.2
Chun, Y.S.3
Palavecino, M.4
Abdalla, E.K.5
Vauthey, J.N.6
-
18
-
-
79954657385
-
Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma
-
Kuang DM, Zhao Q, Wu Y, Peng C, Wang J, Xu Z, et al. Peritumoral neutrophils link inflammatory response to disease progression by fostering angiogenesis in hepatocellular carcinoma. J Hepatol. 2011;54(5):948-55.
-
(2011)
J Hepatol
, vol.54
, Issue.5
, pp. 948-955
-
-
Kuang, D.M.1
Zhao, Q.2
Wu, Y.3
Peng, C.4
Wang, J.5
Xu, Z.6
Yin, X.Y.7
Zheng, L.8
-
19
-
-
77954624557
-
The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma
-
Liu H, Liu G, Bao Q, Sun W, Bao H, Bi L, et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in rectal carcinoma. J Gastrointest Cancer. 2010;41(2):116-20.
-
(2010)
J Gastrointest Cancer
, vol.41
, Issue.2
, pp. 116-120
-
-
Liu, H.1
Liu, G.2
Bao, Q.3
Sun, W.4
Bao, H.5
Bi, L.6
Wen, W.7
Liu, Y.8
Wang, Z.9
Yin, X.10
-
20
-
-
43049133286
-
The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer
-
Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73(3-4):215-20.
-
(2007)
Oncology
, vol.73
, Issue.3-4
, pp. 215-220
-
-
Yamanaka, T.1
Matsumoto, S.2
Teramukai, S.3
Ishiwata, R.4
Nagai, Y.5
Fukushima, M.6
-
21
-
-
84857654110
-
Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer
-
Sato H, Tsubosa Y, Kawano T. Correlation between the pretherapeutic neutrophil to lymphocyte ratio and the pathologic response to neoadjuvant chemotherapy in patients with advanced esophageal cancer. World J Surg. 2012;36(3):617-22.
-
(2012)
World J Surg
, vol.36
, Issue.3
, pp. 617-622
-
-
Sato, H.1
Tsubosa, Y.2
Kawano, T.3
-
22
-
-
84655160810
-
The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma
-
Keizman D, Ish-Shalom M, Huang P, Eisenberger MA, Pili R, Hammers H, et al. The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer. 2012;48(2):202-8.
-
(2012)
Eur J Cancer
, vol.48
, Issue.2
, pp. 202-208
-
-
Keizman, D.1
Ish-Shalom, M.2
Huang, P.3
Eisenberger, M.A.4
Pili, R.5
Hammers, H.6
Carducci, M.A.7
-
23
-
-
33646441904
-
Impact of immune parameters on long-term survival in metastatic renal cell carcinoma
-
Donskov F, von der Maase H. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol. 2006;24(13):1997-2005.
-
(2006)
J Clin Oncol
, vol.24
, Issue.13
, pp. 1997-2005
-
-
Donskov, F.1
Maase, H.2
-
24
-
-
58649105512
-
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer
-
Sarraf KM, Belcher E, Raevsky E, Nicholson AG, Goldstraw P, Lim E. Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surgss. 2009;137(2):425-8.
-
(2009)
J Thorac Cardiovasc Surgss
, vol.137
, Issue.2
, pp. 425-428
-
-
Sarraf, K.M.1
Belcher, E.2
Raevsky, E.3
Nicholson, A.G.4
Goldstraw, P.5
Lim, E.6
-
25
-
-
79953834525
-
Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma
-
An X, Ding PR, Wang FH, Jiang WQ, Li YH. Elevated neutrophil to lymphocyte ratio predicts poor prognosis in nasopharyngeal carcinoma. Tumour Biol. 2011;32(2):317-24.
-
(2011)
Tumour Biol
, vol.32
, Issue.2
, pp. 317-324
-
-
An, X.1
Ding, P.R.2
Wang, F.H.3
Jiang, W.Q.4
Li, Y.H.5
-
26
-
-
84871598079
-
Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram
-
Keizman D, Gottfried M, Ish-Shalom M, Maimon N, Peer A, Neumann A, et al. Pretreatment neutrophil-to-lymphocyte ratio in metastatic castration-resistant prostate cancer patients treated with ketoconazole: association with outcome and predictive nomogram. Oncologist. 2012;17(12):1508-14.
-
(2012)
Oncologist
, vol.17
, Issue.12
, pp. 1508-1514
-
-
Keizman, D.1
Gottfried, M.2
Ish-Shalom, M.3
Maimon, N.4
Peer, A.5
Neumann, A.6
Rosenbaum, E.7
Kovel, S.8
Pili, R.9
Sinibaldi, V.10
-
27
-
-
77649158894
-
NCCN clinical practice guidelines in oncology: prostate cancer
-
Mohler J, Bahnson RR, Boston B, Busby JE, D'Amico A, Eastham JA, et al. NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw. 2010;8(2):162-200.
-
(2010)
J Natl Compr Canc Netw
, vol.8
, Issue.2
, pp. 162-200
-
-
Mohler, J.1
Bahnson, R.R.2
Boston, B.3
Busby, J.E.4
D'Amico, A.5
Eastham, J.A.6
Enke, C.A.7
George, D.8
Horwitz, E.M.9
Huben, R.P.10
-
28
-
-
33745184874
-
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference
-
Roach 3rd M, Hanks G, Thames Jr H, Schellhammer P, Shipley WU, Sokol GH, et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys. 2006;65(4):965-74.
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.65
, Issue.4
, pp. 965-974
-
-
Roach, M.1
Hanks, G.2
Thames, H.3
Schellhammer, P.4
Shipley, W.U.5
Sokol, G.H.6
Sandler, H.7
-
29
-
-
0026600198
-
Data analysis by statistical models
-
Akaike H. Data analysis by statistical models. No To Hattatsu. 1992;24(2):127-33.
-
(1992)
No To Hattatsu
, vol.24
, Issue.2
, pp. 127-133
-
-
Akaike, H.1
-
30
-
-
33751010199
-
Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy
-
Cooperberg MR, Freedland SJ, Pasta DJ, Elkin EP, Presti Jr JC, Amling CL, et al. Multiinstitutional validation of the UCSF cancer of the prostate risk assessment for prediction of recurrence after radical prostatectomy. Cancer. 2006;107(10):2384-91.
-
(2006)
Cancer
, vol.107
, Issue.10
, pp. 2384-2391
-
-
Cooperberg, M.R.1
Freedland, S.J.2
Pasta, D.J.3
Elkin, E.P.4
Presti, J.C.5
Amling, C.L.6
Terris, M.K.7
Aronson, W.J.8
Kane, C.J.9
Carroll, P.R.10
-
31
-
-
0027956699
-
Patient age as a prognostic factor in prostate cancer
-
Gronberg H, Damber JE, Jonsson H, Lenner P. Patient age as a prognostic factor in prostate cancer. J Urol. 1994;152(3):892-5.
-
(1994)
J Urol
, vol.152
, Issue.3
, pp. 892-895
-
-
Gronberg, H.1
Damber, J.E.2
Jonsson, H.3
Lenner, P.4
-
32
-
-
75149189004
-
Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
-
Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol. 2010;6(1):149-63.
-
(2010)
Future Oncol
, vol.6
, Issue.1
, pp. 149-163
-
-
Roxburgh, C.S.1
McMillan, D.C.2
-
33
-
-
51349098155
-
Cytokines as a key component of cancer-related inflammation
-
Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine. 2008;43(3):374-9.
-
(2008)
Cytokine
, vol.43
, Issue.3
, pp. 374-379
-
-
Germano, G.1
Allavena, P.2
Mantovani, A.3
-
34
-
-
79952284127
-
Hallmarks of cancer: the next generation
-
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.
-
(2011)
Cell
, vol.144
, Issue.5
, pp. 646-674
-
-
Hanahan, D.1
Weinberg, R.A.2
-
35
-
-
34248218014
-
Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial
-
Schmidt H, Suciu S, Punt CJ, Gore M, Kruit W, Patel P, et al. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol. 2007;25(12):1562-9.
-
(2007)
J Clin Oncol
, vol.25
, Issue.12
, pp. 1562-1569
-
-
Schmidt, H.1
Suciu, S.2
Punt, C.J.3
Gore, M.4
Kruit, W.5
Patel, P.6
Lienard, D.7
Maase, H.8
Eggermont, A.M.9
Keilholz, U.10
-
36
-
-
67649304466
-
Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03
-
Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: an analysis of Japan Multinational Trial Organisation LC00-03. Eur J Cancer. 2009;45(11):1950-8.
-
(2009)
Eur J Cancer
, vol.45
, Issue.11
, pp. 1950-1958
-
-
Teramukai, S.1
Kitano, T.2
Kishida, Y.3
Kawahara, M.4
Kubota, K.5
Komuta, K.6
Minato, K.7
Mio, T.8
Fujita, Y.9
Yonei, T.10
-
37
-
-
84906938403
-
Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel
-
Sumbul AT, Sezer A, Abali H, Kose F, Gultepe I, Mertsoylu H, et al. Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel. Int Urol Nephrol. 2014;46(8):1531-5.
-
(2014)
Int Urol Nephrol
, vol.46
, Issue.8
, pp. 1531-1535
-
-
Sumbul, A.T.1
Sezer, A.2
Abali, H.3
Kose, F.4
Gultepe, I.5
Mertsoylu, H.6
Muallaoglu, S.7
Ozyilkan, O.8
-
38
-
-
84865324385
-
Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior
-
Gueron G, De Siervi A, Vazquez E. Advanced prostate cancer: reinforcing the strings between inflammation and the metastatic behavior. Prostate Cancer Prostatic Dis. 2012;15(3):213-21.
-
(2012)
Prostate Cancer Prostatic Dis
, vol.15
, Issue.3
, pp. 213-221
-
-
Gueron, G.1
Siervi, A.2
Vazquez, E.3
-
39
-
-
76249101753
-
Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth
-
Houghton AM, Rzymkiewicz DM, Ji H, Gregory AD, Egea EE, Metz HE, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med. 2010;16(2):219-23.
-
(2010)
Nat Med
, vol.16
, Issue.2
, pp. 219-223
-
-
Houghton, A.M.1
Rzymkiewicz, D.M.2
Ji, H.3
Gregory, A.D.4
Egea, E.E.5
Metz, H.E.6
Stolz, D.B.7
Land, S.R.8
Marconcini, L.A.9
Kliment, C.R.10
-
40
-
-
0034783941
-
Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis
-
Shamamian P, Schwartz JD, Pocock BJ, Monea S, Whiting D, Marcus SG, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol. 2001;189(2):197-206.
-
(2001)
J Cell Physiol
, vol.189
, Issue.2
, pp. 197-206
-
-
Shamamian, P.1
Schwartz, J.D.2
Pocock, B.J.3
Monea, S.4
Whiting, D.5
Marcus, S.G.6
Mignatti, P.7
-
41
-
-
0021933069
-
Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes
-
Petrie HT, Klassen LW, Kay HD. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. Open J Immunol. 1985;134(1):230-4.
-
(1985)
Open J Immunol
, vol.134
, Issue.1
, pp. 230-234
-
-
Petrie, H.T.1
Klassen, L.W.2
Kay, H.D.3
-
42
-
-
78650389810
-
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
-
Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, et al. High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16(23):5805-13.
-
(2010)
Clin Cancer Res
, vol.16
, Issue.23
, pp. 5805-5813
-
-
Kao, S.C.1
Pavlakis, N.2
Harvie, R.3
Vardy, J.L.4
Boyer, M.J.5
Zandwijk, N.6
Clarke, S.J.7
-
43
-
-
24344442821
-
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer
-
Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181-4.
-
(2005)
J Surg Oncol
, vol.91
, Issue.3
, pp. 181-184
-
-
Walsh, S.R.1
Cook, E.J.2
Goulder, F.3
Justin, T.A.4
Keeling, N.J.5
-
44
-
-
77957932514
-
High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer
-
Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, Cho A, et al. High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric cance. 2010;13(3):170-6.
-
(2010)
Gastric cance
, vol.13
, Issue.3
, pp. 170-176
-
-
Shimada, H.1
Takiguchi, N.2
Kainuma, O.3
Soda, H.4
Ikeda, A.5
Cho, A.6
Miyazaki, A.7
Gunji, H.8
Yamamoto, H.9
Nagata, M.10
|